[Attitude to questionable cadiac risks in stimulant administration].
Fegert
Jörg M
JM
Klinik fir Kinder- und Jugendpsychiatrie/Psychotherapie am Universitätsklinikum Ulm.
Hebebrand
Johannes
J
D000293:Adolescent; D000328:Adult; D000662:Amphetamines / Q000008:administration & dosage / Q000009:adverse effects*; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D000697:Central Nervous System Stimulants / Q000008:administration & dosage / Q000009:adverse effects*; D002648:Child; D016757:Death, Sudden, Cardiac / Q000453:epidemiology* / Q000517:prevention & control; D064420:Drug-Related Side Effects and Adverse Reactions; D005858:Germany; D006801:Humans; D017410:Practice Guidelines as Topic; D012306:Risk; D014481:United States; D014486:United States Food and Drug Administration
D000662:Amphetamines; D000697:Central Nervous System Stimulants